Lars Erik Bryld
Clinical Associate Professor
1 - 2 out of 2Page size: 10
- 2022
- Published
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
Egeberg, Alexander, Rosenø, N. A. L., Aagaard, D., Lørup, E. H., Nielsen, M., Nymand, L., Kristensen, L. E., Thyssen, Jacob Pontoppidan, Thomsen, Simon Francis, Cordtz, R. L., Loft, N., Skov, Lone, Bryld, Lars Erik, Rasmussen, M. K., Højgaard, P., Kristensen, S. & Dreyer, L., 2022, In: Seminars in Arthritis and Rheumatism. 53, 151979.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study
Loft, N., Egeberg, Alexander, Rasmussen, M. K., Bryld, Lars Erik, Nissen, Christoffer Valdemar S, Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 8, p. 1284-1291 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 32369880
Most downloads
-
77
downloads
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
18
downloads
Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
11
downloads
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published